Provider-guided programs
Peptide membership or pay-as-you-go: which fits you?
Membership fits people who want ongoing education, structured tracking, and rewards over months. Pay-as-you-go fits one-time consultations or short courses of clinically appropriate therapy. The medical decision is identical in both: an independent provider decides, and medication is priced by the pharmacy either way.
Where membership wins
- Continuous education and updated evidence grades
- Longitudinal tools: saved results, journals, assessments
- Points that reduce effective dues over time
- Expert sessions and community
Where pay-as-you-go wins
- One-time questions answered without recurring dues
- Short, defined clinical needs
- No commitment to evaluate
The trap to avoid in either model
Any program where paying more visibly increases your odds of a prescription is structurally compromised. Whichever model you choose, the clinical decision must be independent of the commercial one.
References
- US Food and Drug Administration (2024). FDA's concerns with unapproved GLP-1 drugs used for weight loss. FDA Drug Alerts and Statements. SourceAgency notice
- US Food and Drug Administration (2023). Certain bulk drug substances for use in compounding that may present significant safety risks. FDA Human Drug Compounding. SourceAgency notice
- US Food and Drug Administration (2023). Human drug compounding: compounded drugs are not FDA-approved. FDA. SourceAgency guidance
Found an error? Report a correction.